Sitagliptin impurity E

CAS: 823817-56-7

Ref. 3D-FO103288

Produktinformation

• Name: Sitagliptin impurity E
• Synonyme: 7-[1-Oxo-3-amino-4-(2,4,5-trifluorophenyl)butyl]-3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine
• CAS: 823817-56-7

Beschreibung

Sitagliptin impurity E is an inhibitor of dipeptidyl peptidase-4 (DPP-IV) that is used as a hypoglycemic agent. Sitagliptin impurity E has been shown to increase the glucose-lowering effect in diabetic patients with type 2 diabetes mellitus. It is also effective in reducing postprandial glucose and insulin levels. Sitagliptin impurity E has been shown to increase the concentration of insulin in plasma for up to 24 hours after administration, which suggests that it may be useful for the treatment of metabolic disorders such as obesity and type 2 diabetes mellitus.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 407.31 g/mol
• Formel: C₁₆H₁₅F₆N₅O
• Reinheit: Min. 95%